TrialX
Image

Mechanisms and Innovations in Cardiac Resynchronisation Therapy

Mechanisms and Innovations in Cardiac Resynchronisation Therapy

Recruiting
18 years and older
All
Phase N/A

Overview

The aim of this study is to compare the effectiveness of multiple modalities of cardiac resynchronisation therapy using high precision acute electrical and haemodynamic measurements.These modalities include biventricular pacing and conduction system pacing utilising His bundle and left bundle pacing. Conduction system pacing is a more physiological form of pacing. We hypothesise that this will produce more effective cardiac resynchronisation.

Description

This is a single centre acute electrical/haemodynamic and observational study of a subgroup of patients with heart failure. A total of 60 will be recruited. The acute study involves within patient comparison of biventricular and conduction system pacing using detailed electrical mapping and high precision haemodynamic measurement protocol.

Participants will have permanent conduction system pacing if;

  • Baseline left bundle branch block and QRS > 140ms or QRS >150ms and any QRS morphology AND
  • Conduction system pacing is successful at reducing QRS duration by 20ms or more with satisfactory pacing parameters.

Participants who receive permanent conduction system pacing will have follow up at 6 weeks, 3 months, 6 months and 12 months. Non-invasive markers including mechanical activation pattern (echocardiography and cardiac MRI) and electrical activation pattern (ultra-high frequency electrocardiography) will be used to identify the characteristics of patients who benefit from conduction system pacing.

Eligibility

Inclusion Criteria:

  • Patients referred for conventional CRT
  • Severe heart failure (LVEF, a measure of heart pumping, < 35% - severe)
  • Prolonged QRS duration (>120ms)
  • Adults willing to take part (age > 18 years)
  • Able to give consent

Exclusion Criteria:

  • Unable to give consent
  • Children (age < 18 years)
  • Pregnant women

Study details
    Right bundle branch block
    Heart failure
    Heart failure
    Heart disease
    Heart disease
    Left Ventricular Systolic Dysfunction
    Non-Specific Intraventricular Conduction Defect

NCT04221763

Imperial College London

16 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.